BiondVax Pharmaceuticals (NASDAQ:BVXV) Receives New Coverage from Analysts at StockNews.com

StockNews.com started coverage on shares of BiondVax Pharmaceuticals (NASDAQ:BVXV – Free Report) in a research note issued to investors on Friday morning. The firm issued a hold rating on the stock. BiondVax Pharmaceuticals Price Performance NASDAQ BVXV opened at $1.36 on Friday. BiondVax Pharmaceuticals has a 1 year low of $1.25 and a 1 year […]

Related Keywords

Israel , ,Biondvax Pharmaceuticals ,Sabby Management ,University Medical Center ,Nasdaq ,Exchange Commission ,Biondvax Pharmaceuticals Price Performance ,Hedge Funds Weigh In On Biondvax Pharmaceuticals ,News Ratings For Biondvax Pharmaceuticals Daily ,Max Planck Society ,Biondvax Pharmaceuticals Ltd ,Free Report ,Vax Pharmaceuticals ,Get Free Report ,Vax Pharmaceuticals Ltd ,Biondvax Pharmaceuticals Daily ,Nasdaq Bvxv ,Bvxv ,Medical ,Initiated Coverage ,Stocknews Com ,